To help cancer drugs access tumors, Ting Xu and collaborators are making tiny particles called nanocarriers that protect the drugs during their journey to the tumor. Read the article.
The University of California, Berkeley has joined forces with pharmaceutical giant Novartis to establish a new research collaboration aimed at unlocking difficult drug targets to accelerate the discovery of new medicines in areas such as infectious diseases and cancer.
The College of Chemistry is very pleased to announce that Dr. Paula Hammond, Head of the Department of Chemical Engineering at MIT, will present this year’s Dow Chemical lecture series on Chemical and Biomolecular Engineering at UC Berkeley. The lectures will be held on the Berkeley campus September 18th and 20th.
Daniel Nomura and fellow researchers have found a long-elusive Achilles' heel within "triple-negative" breast tumors, a common type of breast cancer that is difficult to treat.
Newsweek spoke with Jennifer Doudna co-discover of the breakthrough gene-editing technique, about how quickly the technology is advancing and the progress she expects to see in the future.